Zydus Lifesciences has introduced ANVIMO, a breakthrough medication for preventing Cytomegalovirus (CMV) infection in haematopoietic stem cell and kidney transplant patients. The drug, containing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback